| 证券代码 | 证券简称 | 停复牌类型 | 停牌起始日 | 停牌 期间 | 停牌终止日 | 复脚日 | | --- | --- | --- | --- | --- | --- | --- | | 600800 | 渤海化学 | A 股 复牌 | | | 2025/12/19 | 2025/12/22 | 重大资产重组终止。 渤海化学（600800）公告称，公司因筹划出售天津渤海石化有限公司（简称"渤海石化"）100%股权、通 过发行股份及支付现金的方式购买安徽泰达新材料股份有限公司（简称"泰达新材"）的控制权事项，公司 股票于2025年12月8日（星期一）开市起停牌。经审慎研究，公司决定终止本次交易事项，公司股票自 2025年12月22日（星期一）开市起复牌。 值得一提的是，据此前公告，经初步测算，本次交易预计构成《上市公司重大资产重组管理办法》规定的 重大资产重组，本次交易不会导致公司实际控制人发生变更，不构成重组上市。根据《上海证券交易所股 票上市规则》等相关法规，本次交易构成关联交易。 对于终止筹划的原因，公告称，筹划本次交易以来，公司及相关各方严格按照相关法律法规的要求，积极 推动本次交易相关的各 ...

南华期货乙二醇产业周报 ——煤价颓势不改，支撑位再度下调 戴一帆（投资咨询资格证号：Z0015428 ） 研究助理：周嘉伟（期货从业资格证号：F03133676） 交易咨询业务资格：证监许可【2011】1290号 2025年12月21日 第一章 核心矛盾及策略建议 1.1 核心矛盾 总体而言，乙二醇需求端终端订单进一步下滑，需求负反馈将逐步向聚酯环节传导，聚酯需求12月月均 负荷预期91%附近，预计聚酯开工下滑将从12月底起逐步兑现。需求端难抱预期的同时，供应端前期初步释 放支撑信号，部分乙烯制装置集中降负叠加煤制停车装置重启延迟，随着负反馈信号出现静态供需平衡有所 好转，预计估值继续向下大幅压缩的难度提高。但除了自身供需之外，成本端油煤目前仍然维持双弱趋势， 若后续利润随着成本端下行而继续修复，检修预期兑现程度可能将不及预期。因此存量供应仍将长期压制估 值的反弹空间，不低的显性库存也为可能出现的流动性矛盾提供了缓冲空间，供应端或需求端的小幅超预期 若无法扭转长期格局则走势均只能定性为阶段性反弹，对"反转"的期待更可能依赖宏观叙事的驱动，在此之前 过剩预期压制估值以清退边际产能的交易主线逻辑仍将延续。 ∗ 主 ...

Group 1 - The core viewpoint of the article is that Jinhe Industrial's new energy materials business is currently in the laboratory research and preliminary verification stage [2] Group 2 - The company responded to investor inquiries on an interactive platform regarding the status of its new energy materials business [2]

Core Viewpoint - The company announced the approval of several significant proposals by its board, including financing leasing activities and bank credit applications, indicating a strategic move to enhance its financial operations and support future growth [2] Group 1: Financing Activities - The board approved a proposal for the company and its subsidiaries to engage in financing leasing activities, which may provide additional capital and operational flexibility [2] - The approval of related party transactions suggests a focus on leveraging existing relationships to optimize financing structures [2] Group 2: Bank Credit and Guarantees - The company plans to apply for comprehensive credit from banks, which could enhance its liquidity and financial stability [2] - The proposal includes related guarantees, indicating a commitment to secure necessary funding while managing associated risks [2] Group 3: Future Transactions - The board also approved a proposal for expected daily related party transactions for the year 2026, reflecting proactive planning for future operational needs [2]

人民财讯12月19日电，久日新材12月19日在互动平台表示，目前，公司光刻胶产品的销售量处于上升阶 段，预计2026年的产能利用率将逐步提升。 ...

证券日报网讯 12月19日晚间，龙佰集团发布公告称，公司2025年第三次临时股东会审议通过《关于公 司2026年度向银行申请授信额度的议案》《关于为下属子公司担保的议案》《关于开展外汇套期保值业 务的议案》。 （文章来源：证券日报） ...

证券日报网讯12月19日，国泰集团（603977）在互动平台回答投资者提问时表示，公司控股子公司永宁 科技是国内高氯酸钾龙头企业，该产品除了作为烟花鞭炮的原辅材料，还可广泛用于汽车安全气囊、火 箭推进剂、医药、二氧化碳致裂器、发光信号剂及化学试剂等领域。 ...

Core Viewpoint - Changyu Group successfully passed the IPO review by the Shanghai Stock Exchange, marking a significant step towards its public listing [1] Group 1: Company Overview - Changyu Group specializes in the research, production, and sales of zirconium products, specialty nylon products, and fine chemical products, with key products including zirconium oxychloride, zirconium carbonate, zirconium oxide, and specialty nylon [3] - The company is recognized as a leading supplier of zirconium and specialty nylon products, holding the largest global production capacity for zirconium oxychloride and a leading position in specialty nylon production in China [3][4] - Changyu Group's products are widely used in various sectors such as automotive, telecommunications, consumer electronics, high-performance ceramics, and medical fields, with a strong market presence in China, Europe, the United States, Japan, South Korea, India, and Southeast Asia [3] Group 2: Production Capacity and Achievements - The company has an annual production capacity of 75,000 tons for zirconium oxychloride, making it the largest producer globally, and has received recognition as a manufacturing champion from the Ministry of Industry and Information Technology [4] - In the specialty nylon sector, Changyu Group has an annual production capacity of 15,000 tons, leading in domestic capacity and product variety, and has undertaken several major national research projects [4] Group 3: Financial Performance - For the first three quarters of 2023 to 2025, Changyu Group reported revenues of 1.608 billion yuan, 1.638 billion yuan, and 1.321 billion yuan, with net profits of 195 million yuan, 212 million yuan, and 175 million yuan respectively [4] Group 4: IPO Fundraising - The company plans to raise 700 million yuan through its IPO to fund projects including a 45,000-ton ultra-pure zirconium oxychloride and deep processing project, a 10,000-ton high-performance nylon elastomer product project, and a 1,000-ton bioceramics and functional ceramics product project [5]

Core Points - The company has decided to terminate the planning of significant asset sales, issuance of shares, and cash payments for asset purchases and related transactions [1] - The relevant securities will resume trading on December 22, 2025 [1]

Core Viewpoint - Tianji Co., Ltd. announced a delay in the completion of its fundraising project for "30,000 tons of lithium hexafluorophosphate and 6,000 tons of high-purity lithium fluoride" to December 2026, which was previously postponed from December 2024 to December 2025 [1] Financial Performance - For the first three quarters of 2025, the company reported revenue of 1.786 billion yuan, a year-on-year increase of 23.00%, but still incurred a net loss of 101 million yuan [1] - The net cash flow from operating activities was -368 million yuan, with cash received from sales and services amounting to 1.407 billion yuan [1] Debt and Liquidity - As of the third quarter of 2025, the company's interest-bearing debt reached 1.158 billion yuan, a year-on-year increase of 31.26% [2] - Cash and cash equivalents decreased from 977 million yuan in the previous year to 593 million yuan, a decline of 39.35% [2] - The ratio of cash to current liabilities was only 38.17%, and the average operating cash flow to current liabilities ratio over the past three years was 16.91% [2] Project Funding and Use of Proceeds - The fundraising project is expected to require approximately 876 million yuan, with a cumulative investment of 698 million yuan as of November 30, 2025, representing an investment progress of 79.66% [1] - Of the unused fundraising amount (including interest), 175 million yuan has been temporarily used to supplement working capital, leaving approximately 11.12 million yuan in the dedicated fundraising account [1] Shareholder Activity - In September 2025, the controlling shareholder reduced its stake by selling 3 million shares, decreasing its ownership from 18.26% to 17.65% [3] - The reduction was part of a previously disclosed plan allowing for a maximum reduction of 3% of the total share capital within three months after the announcement [3] Market and Operational Challenges - The company cited "customer demand, market environment, and development planning" as reasons for the project delay, while asserting that there are no significant adverse conditions affecting the normal progress of the fundraising plan [3] - The gross margin for the main product, lithium hexafluorophosphate, was reported at -0.5%, indicating a loss [3]